Boxer Capital as of Dec. 31, 2016
Portfolio Holdings for Boxer Capital
Boxer Capital holds 28 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Avexis | 19.0 | $49M | 1.0M | 47.73 | |
| Clovis Oncology | 14.6 | $38M | 850k | 44.42 | |
| Medicines Company | 10.9 | $28M | 828k | 33.94 | |
| Beigene (BGNE) | 10.0 | $26M | 850k | 30.36 | |
| Medicines | 8.2 | $21M | 627k | 33.94 | |
| Blueprint Medicines (BPMC) | 7.7 | $20M | 705k | 28.05 | |
| Aquinox Pharmaceuticals | 5.6 | $15M | 878k | 16.51 | |
| Incyte Corporation (INCY) | 3.9 | $10M | 100k | 100.27 | |
| Alnylam Pharmaceuticals (ALNY) | 3.6 | $9.4M | 250k | 37.44 | |
| Alexion Pharmaceuticals | 3.5 | $9.2M | 75k | 122.35 | |
| Seattle Genetics | 2.0 | $5.3M | 100k | 52.77 | |
| Tesaro | 1.8 | $4.7M | 35k | 134.49 | |
| Mirati Therapeutics | 1.4 | $3.6M | 758k | 4.75 | |
| Kura Oncology (KURA) | 1.2 | $3.1M | 533k | 5.90 | |
| Strongbridge Bioph shs usd | 0.9 | $2.3M | 940k | 2.40 | |
| Sunesis Pharmaceuticals Inc Ne | 0.7 | $1.9M | 525k | 3.62 | |
| Array BioPharma | 0.7 | $1.8M | 200k | 8.79 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $1.7M | 234k | 7.17 | |
| Eiger Biopharmaceuticals | 0.6 | $1.6M | 138k | 11.65 | |
| Aldeyra Therapeutics (ALDX) | 0.6 | $1.6M | 291k | 5.35 | |
| Nabriva Therapeutics | 0.4 | $1.1M | 177k | 5.96 | |
| Aradigm | 0.4 | $1.0M | 635k | 1.60 | |
| Akari Therapeutics | 0.4 | $985k | 140k | 7.04 | |
| Bellerophon Therapeutics | 0.4 | $966k | 1.9M | 0.52 | |
| Onconova Therapeutics | 0.3 | $718k | 316k | 2.27 | |
| Ignyta | 0.3 | $663k | 125k | 5.30 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.2 | $578k | 155k | 3.73 | |
| Onconova Therapeutics Inc *w exp 07/07/202 | 0.1 | $150k | 242k | 0.62 |
